OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Price & Overview
NASDAQ:OSMT
Current stock price
The current stock price of OSMT is 1.11 null. Today OSMT is down by -1.77%. In the past month the price increased by 12.8%. In the past year, price decreased by -75.11%.
OSMT Key Statistics
- Market Cap
- 70.071M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.59
- Dividend Yield
- N/A
OSMT Stock Performance
OSMT Stock Chart
OSMT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to OSMT. When comparing the yearly performance of all stocks, OSMT is a bad performer in the overall market: 92.8% of all stocks are doing better.
OSMT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OSMT. OSMT has a bad profitability rating. Also its financial health evaluation is rather negative.
OSMT Earnings
OSMT Forecast & Estimates
10 analysts have analysed OSMT and the average price target is 5.87 null. This implies a price increase of 428.38% is expected in the next year compared to the current price of 1.11.
For the next year, analysts expect an EPS growth of 18.29% and a revenue growth -89.33% for OSMT
OSMT Groups
Sector & Classification
OSMT Financial Highlights
Over the last trailing twelve months OSMT reported a non-GAAP Earnings per Share(EPS) of -1.59. The EPS decreased by -72.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -150.14% | ||
| ROA | -100.12% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
OSMT Ownership
OSMT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.83 | 869.14B | ||
| JNJ | JOHNSON & JOHNSON | 17.83 | 555.642B | ||
| MRK | MERCK & CO. INC. | 22.11 | 289.223B | ||
| PFE | PFIZER INC | 9.14 | 156.544B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.38 | 120.728B | ||
| ZTS | ZOETIS INC | 16.71 | 51.606B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.57 | 28.443B | ||
| VTRS | VIATRIS INC | 5.91 | 17.315B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.49 | 11.825B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.651B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.206B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.087B | ||
| CORT | CORCEPT THERAPEUTICS INC | 83.11 | 4.929B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OSMT
Company Profile
Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 302 full-time employees. The company went IPO on 2018-10-12. The firm is focused on the developing and commercialization of specialty products that target markets with underserved patient populations. The firm sells portfolio products consisting of promoted products and non-promoted products, which incorporate its Osmodex drug delivery system. The Company’s Osmodex drug delivery system uses osmotic pressure to provide a controlled drug release and is adaptable to many different combinations of immediate-release, extended-release and controlled- or delayed-release formulations that contain one or more drugs. The Company’s non-promoted product portfolio includes methylphenidate ER and venlafaxine extended-release tablets (VERT) as well as ANDAs and prescription dietary supplements. Its promoted products are led by Divigel and M-72 (methylphenidate hydrochloride extended-release tablets, 72 mg).
Company Info
IPO: 2018-10-12
OSMOTICA PHARMACEUTICALS PLC
400 Crossing Blvd
Bridgewater NEW JERSEY 08807 US
CEO: Brian Markison
Employees: 302
Phone: 19088091300.0
OSMOTICA PHARMACEUTICALS PLC / OSMT FAQ
What does OSMT do?
Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 302 full-time employees. The company went IPO on 2018-10-12. The firm is focused on the developing and commercialization of specialty products that target markets with underserved patient populations. The firm sells portfolio products consisting of promoted products and non-promoted products, which incorporate its Osmodex drug delivery system. The Company’s Osmodex drug delivery system uses osmotic pressure to provide a controlled drug release and is adaptable to many different combinations of immediate-release, extended-release and controlled- or delayed-release formulations that contain one or more drugs. The Company’s non-promoted product portfolio includes methylphenidate ER and venlafaxine extended-release tablets (VERT) as well as ANDAs and prescription dietary supplements. Its promoted products are led by Divigel and M-72 (methylphenidate hydrochloride extended-release tablets, 72 mg).
What is the stock price of OSMOTICA PHARMACEUTICALS PLC today?
The current stock price of OSMT is 1.11 null. The price decreased by -1.77% in the last trading session.
What is the dividend status of OSMOTICA PHARMACEUTICALS PLC?
OSMT does not pay a dividend.
What is the ChartMill rating of OSMOTICA PHARMACEUTICALS PLC stock?
OSMT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists OSMT stock?
OSMT stock is listed on the Nasdaq exchange.
Can you provide the growth outlook for OSMOTICA PHARMACEUTICALS PLC?
The Revenue of OSMOTICA PHARMACEUTICALS PLC (OSMT) is expected to decline by -89.33% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for OSMOTICA PHARMACEUTICALS PLC?
OSMOTICA PHARMACEUTICALS PLC (OSMT) currently has 302 employees.